Page last updated: 2024-09-02

trospium chloride and Obesity

trospium chloride has been researched along with Obesity in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chancellor, MB; Oefelein, MG; Vasavada, S	1

Trials

1 trial(s) available for trospium chloride and Obesity

Article	Year
Obesity is associated with a more severe overactive bladder disease state that is effectively treated with once-daily administration of trospium chloride extended release. Neurourology and urodynamics, 2010, Volume: 29, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Benzilates; Body Mass Index; Body Weight; Double-Blind Method; Female; Humans; Middle Aged; Nortropanes; Obesity; Overweight; Parasympatholytics; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence	2010

Article

Year

Obesity is associated with a more severe overactive bladder disease state that is effectively treated with once-daily administration of trospium chloride extended release.

Neurourology and urodynamics, 2010, Volume: 29, Issue:4

Topics: Adult; Aged; Aged, 80 and over; Benzilates; Body Mass Index; Body Weight; Double-Blind Method; Female; Humans; Middle Aged; Nortropanes; Obesity; Overweight; Parasympatholytics; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence

2010